Cost Effectiveness of Glucosamine Sulphate for Knee Arthritis (COGS)

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/402781

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

A clinical trial, conducted in general practice, randomising 340 patients with symptomatic knee osteoarthritis to glucosamine sulphate or matching placebo tablets for 9 months. The main study outcomes will be knee pain, physical function and analgesia use. Analysis will be undertaken to identify characteristics associated with treatment responsiveness, such as high body mass index and structural disease severity. An economic analysis will be conducted alongside this trial.

Funded Activity Details

Start Date: 01-01-2006

End Date: 01-01-2008

Funding Scheme: NHMRC Strategic Awards

Funding Amount: $448,791.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Rheumatology and Arthritis

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

characteristics, structual disease | economis analysis | sulphate, placebo tablets, identify | systomatic knee osteoarthritis, glucosamine

Related Links